The effect of morbid obesity or advanced maternal age on oxytocin-induced myometrial contractions: an in vitro study
- 18 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 67 (7), 836-846
- https://doi.org/10.1007/s12630-020-01615-6
Abstract
Purpose The purpose of this study was to investigate myometrial contractility induced by oxytocin in women with advanced maternal age (AMA) and morbid obesity (MO). We hypothesized that both oxytocin-pretreated and oxytocin-naïve myometrial tissues from women of AMA and women who are MO would exhibit poor myometrial contractility compared with women that are younger and of normal body mass index (BMI). Methods This prospective in vitro study was conducted using myometrial samples obtained from women undergoing elective Cesarean deliveries. Three groups of patient were studied: control (≤ 35 yr; BMI, 20–24.9 kg·m−2), AMA (≥ 40 yr; BMI, 20–24.9 kg·m−2), and MO (≤ 35 yr BMI, ≥ 40 kg·m−2). Each myometrial strip was either pretreated with oxytocin 10−5 M or left in physiologic salt solution for two hours. This was followed by a dose-response testing to oxytocin (10−10 M to 10−5 M), during which contractile parameters were measured. The primary outcome was motility index (MI, amplitude × frequency) of contractions. Results The MI of contractions was reduced in oxytocin-pretreated samples when compared with their oxytocin naïve counterparts in control (estimated difference −69%; 95% confidence interval [CI], −82 to −48; P < 0.001) and AMA groups (estimated difference, −44%; 95% CI, −68 to −2; P = 0.07). The MI of contractions was not different between oxytocin naïve and oxytocin-pretreated samples from MO women (estimated difference, −26%; 95% CI, −63 to 49; P = 0.46); however, it was significantly lower in these groups compared with oxytocin-naïve samples from the control group. Conclusions Oxytocin pre-treatment reduced myometrial contractility in AMA and control group women compared with their oxytocin-naïve counterparts, as a function of the desensitization phenomenon. Attenuated oxytocin-induced myometrial contractility in MO women in both oxytocin-pretreated and oxytocin-naïve samples suggests that these women have intrinsically reduced uterine contractile ability. Trial registration www.clinicaltrials.gov (NCT01865669; registered 28 May, 2013).Keywords
Funding Information
- Canadian Anesthesiologists' Society (CAS-058-2013, CAS-063-2013)
This publication has 41 references indexed in Scilit:
- Oxytocin Pretreatment Attenuates Oxytocin-induced Contractions in Human Myometrium In VitroAnesthesiology, 2013
- Decreased myometrial p160 ROCK-1 expression in obese women at term pregnancyReproductive Biology and Endocrinology, 2013
- What do we know about what happens to myometrial function as women age?Journal of Muscle Research and Cell Motility, 2012
- Altered contribution of RhoA/Rho kinase signaling in contractile activity of myometrium in leptin receptor-deficient miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atonyAmerican Journal of Obstetrics and Gynecology, 2011
- Relationship between gene expression and function of uterotonic systems in the rat during gestation, uterine activation and both term and preterm labourJournal Of Physiology-London, 2008
- The Effect of Delaying Childbirth on Primary Cesarean Section RatesPLoS Medicine, 2008
- Depletion of membrane cholesterol eliminates the Ca2+‐activated component of outward potassium current and decreases membrane capacitance in rat uterine myocytesJournal Of Physiology-London, 2007
- Inhibitory effect of leptin on human uterine contractility in vitroAmerican Journal of Obstetrics and Gynecology, 2006
- Minimum Oxytocin Dose Requirement After Cesarean Delivery for Labor ArrestObstetrics & Gynecology, 2006